| 000 | 01561 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517081000.0 | ||
| 264 | 0 | _c20160623 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1536-5964 | ||
| 024 | 7 |
_a10.1097/MD.0000000000002473 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSánchez-Iglesias, Santiago | |
| 245 | 0 | 0 |
_aRole of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP2D6 Poor Metabolizers Diagnosed With Bipolar Disorder. _h[electronic resource] |
| 260 |
_bMedicine _cFeb 2016 |
||
| 300 |
_ae2473 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 |
_aAntidepressive Agents, Second-Generation _xadverse effects |
| 650 | 0 | 4 |
_aBipolar Disorder _xdrug therapy |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2D6 _xgenetics |
| 650 | 0 | 4 | _aGenetic Markers |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPatient Safety |
| 650 | 0 | 4 | _aQuality Improvement |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGarcía-Solaesa, Virginia | |
| 700 | 1 | _aGarcía-Berrocal, Belén | |
| 700 | 1 | _aSanchez-Martín, Almudena | |
| 700 | 1 | _aLorenzo-Romo, Carolina | |
| 700 | 1 | _aMartín-Pinto, Tomás | |
| 700 | 1 | _aGaedigk, Andrea | |
| 700 | 1 | _aGonzález-Buitrago, José Manuel | |
| 700 | 1 | _aIsidoro-García, María | |
| 773 | 0 |
_tMedicine _gvol. 95 _gno. 6 _gp. e2473 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MD.0000000000002473 _zAvailable from publisher's website |
| 999 |
_c25728007 _d25728007 |
||